depression tirzepatide Weight-Loss Drugs Like Wegovy Now Linked to Lower Risk Can Tirzepatide Cause Depression?

This can be particularly beneficial for individuals who are overweight and have other health issues related to their weight, such as high blood pressure or cholesterol

Proper sharps disposal is a legal and public health requirement in the UK

In May 2025, CVS Caremark announced that anti-obesity (AOM) tirzepatide (sold as Zepbound) would be removed from its preferred formulary effective July 1, 2025, with AOM semaglutide (sold as Wegovy) designated as the preferred alternative

FDA-Approved Brand-Name Medications (via insurance): Wegovy (semaglutide) FDA-approved for weight loss Zepbound (tirzepatide) FDA-approved for weight loss Ozempic and Mounjaro (off-label for weight loss, via insurance) Compounded Alternatives (cash-pay, when appropriate): Compounded semaglutide, which may include glycine (to support muscle preservation) and Vitamin B12 (cyanocobalamin, to help reduce nausea) Compounded tirzepatide Oral Rybelsus (oral semaglutide) as an FDA-approved alternative for appropriate patients Zealthy states it does not offer commercially available copies of semaglutide or tirzepatide unless there is an official FDA-declared shortage, a policy commitment that, if maintained, would align with current post-shortage FDA regulations

Obesity rates are highest among Black and Latinx adults, people in rural areas, and people with low incomes